Axial Spondyloarthritis: Current Advances, Future Challenges.

Area of Science:

• Rheumatology and Immunology
• Genetics and Environmental Factors
• Microbiome Research

Background:

• Axial spondyloarthritis (axSpA) is a chronic inflammatory disease affecting young adults, leading to pain, fatigue, and potential spinal disability.
• Early diagnosis of axSpA is challenging but critical, as timely intervention with biologics can modify disease progression.
• Genetic and environmental factors contribute to axSpA susceptibility, with recent focus on the gut microbiome's role.

Purpose of the Study:

• To address the unmet needs in early identification and management of axSpA.
• To explore the immunological connections within the gut-joint axis in axSpA.
• To identify novel therapeutic targets for axSpA.

Main Methods:

• Review of recent clinical and experimental studies on axSpA.
• Analysis of genetic susceptibility factors.
• Investigation of the gut microbiome and its immunological implications.

Main Results:

• Advances in understanding axSpA genetics and environmental influences, including the gut microbiome.
• Emerging insights into the immunology of the gut-joint axis.
• Identification of key research areas for future axSpA studies.

Conclusions:

• Improved early case identification and sensitive biomarkers are needed for axSpA.
• Understanding shared inflammatory pathways in axSpA (skin, eye, gut) is essential.
• Novel therapeutic strategies targeting curative potential are a priority for axSpA research.